OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q1 2026 Earnings Call Transcript
OSUR - OraSure Technologies, Inc.
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$4.00
DETAILS
HIGH:
$4.00
LOW:
$4.00
MEDIAN:
$4.00
CONSENSUS:
$4.00
UPSIDE:
10.80%
Stock News
OraSure Announces First Quarter 2026 Financial Results
BETHLEHEM, Pa., May 06, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its financial results for the three months ended March 31, 2026.
OraSure to Announce First Quarter 2026 Financial Results and Host Earnings Call on May 6th
BETHLEHEM, Pa., April 22, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering first quarter 2026 financial results and certain business developments for 5 p.m. ET on May 6, 2026.
OraSure Technologies Appoints John D. Bertrand to its Board of Directors
Enters into Cooperation Agreement with Altai Capital Board to Seek Shareholder Approval for Declassification at the 2026 Annual Meeting BETHLEHEM, Pa., April 16, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the appointment of John D.
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above Two Hundred Day Moving Average – Here’s Why
OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report)'s share price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $2.77 and traded as high as $3.08. OraSure Technologies shares last traded at $3.06, with a volume of 304,439 shares traded. Wall Street Analyst Weigh In
OraSure Technologies (NASDAQ:OSUR) Stock Crosses Above 200-Day Moving Average – Here’s What Happened
Shares of OraSure Technologies, Inc. (NASDAQ: OSUR - Get Free Report) crossed above its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $2.78 and traded as high as $2.99. OraSure Technologies shares last traded at $2.92, with a volume of 402,952 shares. Analyst Ratings Changes Separately, Weiss Ratings
OraSure Highlights Significant Operational Progress and Value Creation Initiatives Following Letter from Altai Capital
Company Has Demonstrated Momentum on Transformation Strategy with Significant Regulatory and Commercial Milestones Approaching in 2026 Highlights Extensive Engagement with Altai Altai Has Rejected All Settlement Proposals and Is Singularly Focused on Securing Board Representation for Its Founder to Force an Ill-Timed Sale Process BETHLEHEM, Pa., March 17, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and the “Company”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today issued the following statement in response to Altai Capital's March 17, 2026, letter: OraSure's Board and management team are steadfast in our commitment to driving value and acting in the best interests of all shareholders through disciplined execution and rigorous oversight.
Altai Capital Management Issues Letter to OraSure Board Outlining Five-Pillar Case for Change in Response to Significant and Continued Underperformance
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and the beneficial owners of approximately 5% of the outstanding common stock of OraSure Technologies, Inc. (“OraSure” or the “Company”) (NASDAQ: OSUR), today announced that it has delivered a letter to the OraSure Board of Directors (the “Board”) outlining a five-pillar case for why change is necessary to preserve and deliver value for its investors. In the letter, Altai calls on the OraSure.
Exclusive: Altai Capital presses OraSure to sell and give it board seats, letter says
Activist investor Altai Capital Management called on OraSure Technologies to explore a sale, saying the medical device maker could fetch double its current share price, according to a letter seen by Reuters.
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
OraSure Technologies, Inc. (OSUR) Q4 2025 Earnings Call Transcript
Agape ATP (NASDAQ:ATPC) vs. OraSure Technologies (NASDAQ:OSUR) Head to Head Survey
OraSure Technologies (NASDAQ: OSUR - Get Free Report) and Agape ATP (NASDAQ: ATPC - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, earnings, analyst recommendations, institutional ownership and profitability. Analyst Recommendations This is a breakdown of
OraSure to Launch OraQuick™ HIV Self-Test in Canada
BETHLEHEM, Pa., Feb. 10, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced its OraQuick™ HIV Self-Test has received a license from Health Canada for use in Canada.
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
BETHLEHEM, Pa., Feb. 09, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering fourth quarter 2025 financial results and certain business developments for 5 p.m. ET on February 25, 2026.
OraSure Technologies Confirms Receipt of Director Nominations from Altai Capital
BETHLEHEM, Pa., Jan. 15, 2026 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OraSure” and “OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today confirmed that Altai Capital (“Altai”) has nominated two candidates, including the fund's founder Rishi Bajaj, to stand for election to the Company's Board of Directors (the “Board”) at its 2026 Annual Meeting of Stockholders.
Altai Capital Management Nominates Two Highly-Qualified Candidates for Election to OraSure Board of Directors
LOS ANGELES--(BUSINESS WIRE)--Altai Capital Management, L.P. ("Altai"), one of the largest shareholders and beneficial owners of approximately 5.2% of the outstanding common stock of OraSure Technologies, Inc. (“OraSure” or the “Company”) (NASDAQ: OSUR), today announced that it has nominated two highly-qualified candidates, John Bertrand, Co-Founder of Digital Diagnostics, and Rishi Bajaj, President and CIO of Altai, for election to the OraSure Board of Directors (the “Board”) at the 2026 Annua.